Accuracy of the CUETO, EORTC 2016 and EAU 2021 scoring models and risk stratification tables to predict outcomes in high–grade non-muscle-invasive urothelial bladder cancerWojciech Krajewski, Ekaterina Laukhtina, Bartosz Małkiewicz et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 29
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non–muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk DynamicsJosé Daniel Subiela, F.J. Burgos Revilla, Wojciech Krajewski et al.|European Urology Oncology|2024Cited by 20
The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant ChemotherapyDavid D‘Andrea, Marco Moschini, Shahrokh F. Shariat et al.|European Urology Open Science|2022Cited by 14
Androgen Deprivation Therapy in Patients With Prostate Cancer Increases Serum Levels of Thromboxane A2: Cardiovascular ImplicationsMario Álvarez‐Maestro, Mercedes Ferrer|Frontiers in Cardiovascular Medicine|2021Cited by 10